7103 related articles for article (PubMed ID: 24133582)
1. Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas.
Zheng J; Xu J; Ma S; Sun X; Geng M; Wang L
Int J Clin Exp Pathol; 2013; 6(10):2048-55. PubMed ID: 24133582
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
4. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
[TBL] [Abstract][Full Text] [Related]
5. Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.
Hattab EM; Martin SE; Al-Khatib SM; Kupsky WJ; Vance GH; Stohler RA; Czader M; Al-Abbadi MA
Mod Pathol; 2010 Feb; 23(2):235-43. PubMed ID: 19935644
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
9. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
10. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.
Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S
Hum Pathol; 2003 Jun; 34(6):610-6. PubMed ID: 12827616
[TBL] [Abstract][Full Text] [Related]
11. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
[TBL] [Abstract][Full Text] [Related]
12. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
[TBL] [Abstract][Full Text] [Related]
13. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
Sugita Y; Tokunaga O; Nakashima A; Shigemori M
Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
[TBL] [Abstract][Full Text] [Related]
14. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
[TBL] [Abstract][Full Text] [Related]
16. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
[TBL] [Abstract][Full Text] [Related]
17. Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.
Zhang J; Sun J; Feng J; Luo Y; Ling Q; Wu S; Zeng X; Liang Z
Virchows Arch; 2018 Jul; 473(1):95-103. PubMed ID: 29802470
[TBL] [Abstract][Full Text] [Related]
18. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
19. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes.
Rao S; Epari S; Shet TM; Gujral S; Jain H; Bagal B; Senagar M; Shetty P; Moiyadi A; Goda JS; Gupta T
Indian J Pathol Microbiol; 2023; 66(3):549-555. PubMed ID: 37530337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
